Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $24.15.
Several research firms have recently commented on DOC. Wells Fargo & Company reduced their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 10th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. Mizuho decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a "hold" rating to a "buy" rating and increased their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st.
View Our Latest Report on DOC
Healthpeak Properties Price Performance
Shares of NYSE:DOC traded down $0.28 during midday trading on Friday, hitting $19.58. The company had a trading volume of 5,357,266 shares, compared to its average volume of 4,816,806. Healthpeak Properties has a twelve month low of $16.01 and a twelve month high of $23.26. The stock has a market cap of $13.70 billion, a price-to-earnings ratio of 55.94, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31. The business's 50-day simple moving average is $20.54 and its 200-day simple moving average is $21.52.
Healthpeak Properties Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be issued a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 6.23%. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date is Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is 342.87%.
Hedge Funds Weigh In On Healthpeak Properties
Institutional investors have recently bought and sold shares of the company. HM Payson & Co. purchased a new position in shares of Healthpeak Properties in the third quarter valued at approximately $25,000. S.A. Mason LLC purchased a new position in Healthpeak Properties in the 3rd quarter valued at approximately $26,000. Rise Advisors LLC purchased a new position in Healthpeak Properties in the 3rd quarter valued at approximately $29,000. Fortitude Family Office LLC acquired a new position in shares of Healthpeak Properties in the third quarter worth $32,000. Finally, Barrett & Company Inc. purchased a new stake in shares of Healthpeak Properties during the third quarter worth $33,000. 93.57% of the stock is owned by institutional investors and hedge funds.
Healthpeak Properties Company Profile
(
Get Free ReportHealthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.